Skip to main content
Log in

Making Sense of SNPs: Women’s Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks

  • Original Research
  • Published:
Journal of Genetic Counseling

Abstract

Genome wide association studies have identified a number of common genetic variants - single nucleotide polymorphisms (SNPs) – that combine to increase breast cancer risk. SNP profiling may enhance the accuracy of risk assessment and provides a personalized risk estimate. SNP testing for breast cancer risks may supplement other genetic tests in the future, however, before it can be implemented in the clinic we need to know how it will be perceived and received. Semi-structured qualitative interviews were conducted with 39 women who had previously had a breast cancer diagnosis and undergone BRCA1/2 testing, participated in the Variants in Practice (ViP) study and received personalized risk (SNP) profiles. Interviews explored their understanding and experiences of receiving this SNP information. Women reported feeling positive about receiving their personalized risk profile, because it: provided an explanation for their previous diagnosis of cancer, vindicated previous risk management decisions and clarified their own and other family members’ risks. A small group was initially shocked to learn of the increased risk of a second primary breast cancer. This study suggests that the provision of personalized risk information about breast cancer generated by SNP profiling is understood and well received. However, a model of genetic counseling that incorporates monogenic and polygenic genetic information will need to be developed prior to clinical implementation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Ahmed, S., Thomas, G., Ghoussaini, M., Healey, C. S., Humphreys, M. K., Platte, R., et al. (2009). Newly discovered breast cancer susceptibility loci on 3p24 and 17q23. 2. Nature Genetics, 41(5), 585–590.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Anderson, A. E., Flores, K. G., Boonyasiriwat, W., Gammon, A., Kohlmann, W., Birmingham, W. C., et al. (2014). Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk. Public Health Genomics, 17(1), 48–60. https://doi.org/10.1159/000356567.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Antoniou, A. C., Wang, X., Fredericksen, Z. S., McGuffog, L., Tarrell, R., Sinilnikova, O. M., et al. (2010). A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature Genetics, 42(10), 885–892.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Austin, J. C., & Peay, H. L. (2006). Applications and limitations of empiric data in provision of recurrence risks for schizophrenia: a practical review for healthcare professionals providing clinical psychiatric genetics consultations. Clinical Genetics, 70(3), 177–187. https://doi.org/10.1111/j.1399-0004.2006.00658.x.

    Article  CAS  PubMed  Google Scholar 

  • Chapman, E., & Bilton, D. (2004). Patients’ knowledge of cystic fibrosis: Genetic determinism and implications for treatment. Journal of Genetic Counseling, 13(5), 369–385. https://doi.org/10.1023/B:JOGC.0000044199.38694.6c.

    Article  PubMed  Google Scholar 

  • Chowdhury, S., Dent, T., Pashayan, N., Hall, A., Lyratzopoulos, G., Hallowell, N., et al. (2013a). Incorporating genomics into breast and prostate cancer screening: Assessing the implications. Genetics in Medicine, 15(6), 423–432. https://doi.org/10.1038/gim.2012.167.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chowdhury, S., Dent, T., Pashayan, N., Hall, A., Lyratzopoulos, G., Hallowell, N., et al. (2013b). Incorporating genomics into breast and prostate cancer screening: Assessing the implications. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 15(6), 423–432. https://doi.org/10.1038/gim.2012.167.

    Article  CAS  Google Scholar 

  • Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2004). Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women’s looking back on the pre-test period and a psychological evaluation. Genetic Testing, 8(1), 13–21.

    Article  PubMed  Google Scholar 

  • Collins, R. E., Wright, A. J., & Marteau, T. M. (2011). Impact of communicating personalized genetic risk information on perceived control over the risk: A systematic review. Genetics in Medicine, 13(4), 273–277. https://doi.org/10.1097/GIM.0b013e3181f710ca.

    Article  PubMed  Google Scholar 

  • Cox, A., Dunning, A. M., Garcia-Closas, M., Balasubramanian, S., Reed, M. W., Pooley, K. A., et al. (2007). A common coding variant in CASP8 is associated with breast cancer risk. Nature Genetics, 39(3), 352–358.

    Article  CAS  PubMed  Google Scholar 

  • Dent, T., Jbilou, J., Rafi, I., Segnan, N., Tornberg, S., Chowdhury, S., et al. (2013). Stratified cancer screening: The practicalities of implementation. Public Health Genomics, 16(3), 94–99. https://doi.org/10.1159/000345941.

    Article  CAS  PubMed  Google Scholar 

  • Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D., Thompson, D., Ballinger, D. G., et al. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447(7148), 1087–1093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Egglestone, C., Morris, A., & O'Brien, A. (2013). Effect of direct-to-consumer genetic tests on health behaviour and anxiety: a survey of consumers and potential consumers. Journal of Genetic Counseling, 22(5), 565–575. https://doi.org/10.1007/s10897-013-9582-6.

    Article  PubMed  Google Scholar 

  • Fisher, C. L., Maloney, E., Glogowski, E., Hurley, K., Edgerson, S., Lichtenthal, W. G., et al. (2014). Talking about familial breast cancer risk: Topics and strategies to enhance mother-daughter interactions. Qualitative Health Research, 24(4), 517–535. https://doi.org/10.1177/1049732314524638.

    Article  PubMed  Google Scholar 

  • Fletcher, O., Johnson, N., Orr, N., Hosking, F. J., Gibson, L. J., Walker, K., et al. (2011). Novel breast cancer susceptibility locus at 9q31. 2: Results of a genome-wide association study. Journal of the National Cancer Institute, 103(5), 425–435.

    Article  CAS  PubMed  Google Scholar 

  • Ghoussaini, M., Fletcher, O., Michailidou, K., Turnbull, C., Schmidt, M. K., Dicks, E., et al. (2012). Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature Genetics, 44(3), 312–318.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Goldstein, D. B. (2009). Common genetic variation and human traits. The New England Journal of Medicine, 360(17), 1696–1698. https://doi.org/10.1056/NEJMp0806284.

    Article  CAS  PubMed  Google Scholar 

  • Hall, A. E., Chowdhury, S., Hallowell, N., Pashayan, N., Dent, T., Pharoah, P., & Burton, H. (2014). Implementing risk-stratified screening for common cancers: A review of potential ethical, legal and social issues. Journal of Public Health (Oxford, England), 36(2), 285–291. https://doi.org/10.1093/pubmed/fdt078.

    Article  CAS  Google Scholar 

  • Hallowell, N., Arden-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., & Watson, M. (2006). Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociology of Health & Illness, 28(7), 969–988. https://doi.org/10.1111/j.1467-9566.2006.00515.x.

    Article  Google Scholar 

  • Howe, R., Miron-Shatz, T., Hanoch, Y., Omer, Z. B., O'Donoghue, C., & Ozanne, E. M. (2014). Personalized medicine through SNP testing for breast cancer Risk: Clinical Implementation. Journal of Genetic Counseling, 24(5), 744–751. https://doi.org/10.1007/s10897-014-9803-7.

    Article  PubMed  Google Scholar 

  • Leventhal, K. G., Tuong, W., Peshkin, B. N., Salehizadeh, Y., Fishman, M. B., Eggly, S., et al. (2013). "is it really worth it to get tested?": Primary care patients' impressions of predictive SNP testing for colon cancer. Journal of Genetic Counseling, 22(1), 138–151. https://doi.org/10.1007/s10897-012-9530-x.

    Article  PubMed  Google Scholar 

  • Lodder, L., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G., Duivenvoorden, H. J., et al. (2001). Psychological impact of receiving a BRCA1/BRCA2 test result. American Journal of Medical Genetics, 98(1), 15–24.

    Article  CAS  PubMed  Google Scholar 

  • Mavaddat, N., Pharoah, P. D., Michailidou, K., Tyrer, J., Brook, M. N., Bolla, M. K., et al. (2015). Prediction of breast cancer risk based on profiling with common genetic variants. Journal of the National Cancer Institute, 107(5). https://doi.org/10.1093/jnci/djv036.

  • McClure, J. B. (2002). Are biomarkers useful treatment aids for promoting health behavior change? An empirical review. American Journal of Preventive Medicine, 22(3), 200–207.

    Article  PubMed  Google Scholar 

  • Michailidou, K., Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., Milne, R. L., et al. (2013). Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nature Genetics, 45(4), 353–361, 361e351-352. https://doi.org/10.1038/ng.2563.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Michailidou, K., Beesley, J., Lindstrom, S., Canisius, S., Dennis, J., Lush, M. J., et al. (2015). Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Genetics, 47(4), 373–380. https://doi.org/10.1038/ng.3242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Offit, K. (2008). Genomic profiles for disease risk: Predictive or premature? JAMA, 299(11), 1353–1355. https://doi.org/10.1001/jama.299.11.1353.

    Article  CAS  PubMed  Google Scholar 

  • Sawyer, S., Mitchell, G., McKinley, J., Chenevix-Trench, G., Beesley, J., Chen, X. Q., et al. (2012). A role for common genomic variants in the assessment of familial breast cancer. Journal of Clinical Oncology, 30(35), 4330–4336.

    Article  PubMed  Google Scholar 

  • Sehrawat, B., Sridharan, M., Ghosh, S., Robson, P., Cass, C. E., Mackey, J. R., et al. (2011). Potential novel candidate polymorphisms identified in genome-wide association study for breast cancer susceptibility. Human Genetics, 130(4), 529–537.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stacey, S. N., Manolescu, A., Sulem, P., Thorlacius, S., Gudjonsson, S. A., Jonsson, G. F., et al. (2008). Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer. Nature Genetics, 40(6), 703–706.

    Article  CAS  PubMed  Google Scholar 

  • Strauss, A., & Corbin, J. (1990). Basics of qualitative research: Grounded theory procedures and techniques. Newbury Park: Sage Publications.

    Google Scholar 

  • Taber, J. M., Aspinwall, L. G., Stump, T. K., Kohlmann, W., Champine, M., & Leachman, S. A. (2015). Genetic test reporting enhances understanding of risk information and acceptance of prevention recommendations compared to family history-based counseling alone. Journal of Behavioral Medicine, 38(5), 740–753. https://doi.org/10.1007/s10865-015-9648-z.

    Article  PubMed  PubMed Central  Google Scholar 

  • van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H. J., Brocker-Vriends, A. H., van Asperen, C. J., Sijmons, R. H., et al. (2007). A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. Psychooncology, 16(4), 320–328. https://doi.org/10.1002/pon.1062.

    Article  PubMed  Google Scholar 

  • van Roosmalen, M. S., Stalmeier, P. F., Verhoef, L. C., Hoekstra-Weebers, J. E., Oosterwijk, J. C., Hoogerbrugge, N., et al. (2004). Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. American Journal of Medical Genetics. Part A, 124A(4), 346–355. https://doi.org/10.1002/ajmg.a.20374.

    Article  PubMed  Google Scholar 

  • Waxler, J. L., O'Brien, K. E., Delahanty, L. M., Meigs, J. B., Florez, J. C., Park, E. R., et al. (2012). Genetic counseling as a tool for type 2 diabetes prevention: A genetic counseling framework for common polygenetic disorders. Journal of Genetic Counseling, 21(5), 684–691. https://doi.org/10.1007/s10897-012-9486-x.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the women who participated in the ViP study, particularly those who took part in the psychosocial study.

This work was supported by the Australian National Health and Medical Research Council (2012-2014, APP1023698). A Cancer Council Victoria postgraduate scholarship supports Miss Sarah D Sawyer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mary-Anne Young.

Ethics declarations

Conflict of Interest

Mary-Anne Young declares that she has no conflict of interest.

Laura Elenor Forrest declares that she has no conflict of interest.

Victoria-Mae Rasmussen declares that she has no conflict of interest.

Paul James declares that he has no conflict of interest.

Gillian Mitchell declares that she has no conflict of interest.

Sarah Dilys Sawyer declares that she has no conflict of interest.

Katrina Reeve declares that she has no conflict of interest.

Nina Hallowell declares that she has no conflict of interest.

Human Studies and Informed Consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.

Animal Studies

No animal studies were carried out by the authors for this article.

Electronic Supplementary Material

ESM 1

(DOC 30 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Young, MA., Forrest, L.E., Rasmussen, VM. et al. Making Sense of SNPs: Women’s Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks. J Genet Counsel 27, 702–708 (2018). https://doi.org/10.1007/s10897-017-0162-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10897-017-0162-z

Keywords

Navigation